Trust & Proof: RADICAVA ORS® (edaravone) – Signal Evidence & AI Readability

RADICAVA ORS® (edaravone)

(https://radicava.com) 📸 Data Snapshot: June 19, 2026
Trust & Proof — The Lens

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Trust & Proof Verifiable evidence vs. Trust Theatre.
9 Impact Weight: 20 / 100
45% Reputation

The site triggers trust theatre flags due to the presence of patient testimonials (review_count 4-6 per page) without direct outbound proof links in the metadata. While footnotes cite the FDA and clinical studies, the testimonials from individuals like ‘Gwen’ and ‘Juan’ are noted as ‘Paid Consultants,’ which technically categorizes them as marketing assets rather than independent verification. The lack of direct external links to peer-reviewed publications within the body text, relying instead on internal footnotes, adds minor weight to this pillar.

Proof density is high, featuring exact numbers, percentages, and dated results (‘as of January 2026’). The site provides technical specifications for administration (5 mL syringe, storage at 68-77 degrees) and cites the ALSFRS-R scale as its primary metric. The only minor gap is the reliance on ‘prescriptions submitted’ for patient volume counts, which the site admits are ‘not independently verified.’

Trust & Proof is read by weighing trust language against real verification. Below is the page-by-page tally of review mentions and external proof links, then the schema markup that may (or may not) declare verifiable ratings and identity proof.

🛡️ Trust Signals — reviews, proof links, trust-theatre check
20Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 5 0
/patient/ 5 0
/patient/educational-webinar/ 6 0
/patient/understanding-radicava/ 4 0
🔗 Identity & Technical Layer — schema JSON-LD: declared ratings, reviews & identity proof
Homepage schema
{
    "@context": "https://schema.org",
    "@type": "Organization",
    "url": "https://www.radicava.com/patient/",
    "logo": "https://www.radicava.com/logo_radicava_ors.svg",
    "name": "RADICAVA ORS® (edaravone)",
    "description": "Explore clinical data, real-world stories, dosing guides, financial assistance and JourneyMate support resources for RADICAVA ORS® (edaravone) ALS treatment."
}
/patient/
{
    "@context": "https://schema.org",
    "@type": "Organization",
    "url": "https://www.radicava.com/patient/",
    "logo": "https://www.radicava.com/logo_radicava_ors.svg",
    "name": "RADICAVA ORS® (edaravone)",
    "description": "Explore clinical data, real-world stories, dosing guides, financial assistance and JourneyMate support resources for RADICAVA ORS® (edaravone) ALS treatment."
}
/patient/educational-webinar/
{
    "@context": "https://schema.org",
    "@type": "Organization",
    "url": "https://www.radicava.com/patient/educational-webinar/",
    "logo": "https://www.radicava.com/logo_radicava_ors.svg",
    "name": "RADICAVA ORS® (edaravone)",
    "description": "Watch neurologists and ALS specialists discuss RADICAVA ORS® (edaravone), disease management and emerging research in our on-demand webinars."
}
/patient/understanding-radicava/
{
    "@context": "https://schema.org",
    "@type": "Organization",
    "url": "https://www.radicava.com/patient/understanding-radicava/",
    "logo": "https://www.radicava.com/logo_radicava_ors.svg",
    "name": "RADICAVA ORS® (edaravone)",
    "description": "Review efficacy data, safety profile and patient support resources that make RADICAVA ORS® (edaravone) a treatment option for ALS."
}